ADA and tuberculosis: We did not evaluate the potential impact on morbidity and length of hospital stay of ADA, IFN-γ and Xpert compared to empiric treatment based on laboratory analysis alone (lymphocyte predominance), however, this would have require a randomized design and up to ~25% of TB effusions are known to be neutrophil pre-dominant [23].